Cargando…

Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study

Objective: The clinical characteristics of patients with PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) and PANS (pediatric acute-onset neuropsychiatric syndrome) and the efficacy of antibiotic therapy with psychotherapy and antipsychotics were inves...

Descripción completa

Detalles Bibliográficos
Autores principales: Rea, Isabella, Guido, Cristiana Alessia, Spalice, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505529/
https://www.ncbi.nlm.nih.gov/pubmed/34650513
http://dx.doi.org/10.3389/fneur.2021.741176
_version_ 1784581552841162752
author Rea, Isabella
Guido, Cristiana Alessia
Spalice, Alberto
author_facet Rea, Isabella
Guido, Cristiana Alessia
Spalice, Alberto
author_sort Rea, Isabella
collection PubMed
description Objective: The clinical characteristics of patients with PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) and PANS (pediatric acute-onset neuropsychiatric syndrome) and the efficacy of antibiotic therapy with psychotherapy and antipsychotics were investigated to improve neurological symptoms as well as obsessive compulsive disorder (OCD). Methods: We retrospectively analyzed 62 patients with a clinical diagnosis of PANDAS/PANS enrolled from May 14, 2013 to September 15, 2020 in the Neurology Childhood Division, Department of Pediatrics at Sapienza, Rome. Clinical manifestations, neurological and psychiatric, laboratory investigations, and familiar history were collected to evaluate the differences between the two groups. The effects of various therapeutic approaches were examined. Descriptive and comparative statistical analyses were performed. Results: The mean age at onset of PANDAS/PANS symptoms was 6.2 ± 1.2 years. The most common diagnosis was PANDAS, followed by PANS. Neurological and psychiatric symptoms were mostly evident in both groups (>70% of the population), with no significant difference between them (P = 0.52 and P = 0.15, respectively). Irritability, aggressivity, and food restriction were more prevalent in children with PANS than in those with PANDAS (P = 0.024 and P = 0.0023, respectively). The levels of anti-streptolysin O and anti-DNAse B 10-fold higher in PANDAS than those in PANS (P < 0.0001). Antibiotics or psychotherapy were administered in most cases (90.3 and 53.2%, respectively), followed by antipsychotic treatments (24.2%). In the multivariate analysis, among the therapies used, psychotherapy significantly resulted in the most efficacious relief of OCD, reducing stress in patients and their parents (P = 0.042). Conclusion: Our findings confirm a clear clinical difference between the two groups, PANDAS and PANS, using different approaches. In fact, irritability, aggressivity, and food restriction were significantly more frequent in children with PANS and the levels of anti-streptolysin O and anti-DNAse B were higher in PANDAS. Another relevant finding is the efficacy of psychotherapy, especially for obsessive-compulsive disorder, and of antibiotic prophylaxis in managing acute neurological symptoms.
format Online
Article
Text
id pubmed-8505529
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85055292021-10-13 Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study Rea, Isabella Guido, Cristiana Alessia Spalice, Alberto Front Neurol Neurology Objective: The clinical characteristics of patients with PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infection) and PANS (pediatric acute-onset neuropsychiatric syndrome) and the efficacy of antibiotic therapy with psychotherapy and antipsychotics were investigated to improve neurological symptoms as well as obsessive compulsive disorder (OCD). Methods: We retrospectively analyzed 62 patients with a clinical diagnosis of PANDAS/PANS enrolled from May 14, 2013 to September 15, 2020 in the Neurology Childhood Division, Department of Pediatrics at Sapienza, Rome. Clinical manifestations, neurological and psychiatric, laboratory investigations, and familiar history were collected to evaluate the differences between the two groups. The effects of various therapeutic approaches were examined. Descriptive and comparative statistical analyses were performed. Results: The mean age at onset of PANDAS/PANS symptoms was 6.2 ± 1.2 years. The most common diagnosis was PANDAS, followed by PANS. Neurological and psychiatric symptoms were mostly evident in both groups (>70% of the population), with no significant difference between them (P = 0.52 and P = 0.15, respectively). Irritability, aggressivity, and food restriction were more prevalent in children with PANS than in those with PANDAS (P = 0.024 and P = 0.0023, respectively). The levels of anti-streptolysin O and anti-DNAse B 10-fold higher in PANDAS than those in PANS (P < 0.0001). Antibiotics or psychotherapy were administered in most cases (90.3 and 53.2%, respectively), followed by antipsychotic treatments (24.2%). In the multivariate analysis, among the therapies used, psychotherapy significantly resulted in the most efficacious relief of OCD, reducing stress in patients and their parents (P = 0.042). Conclusion: Our findings confirm a clear clinical difference between the two groups, PANDAS and PANS, using different approaches. In fact, irritability, aggressivity, and food restriction were significantly more frequent in children with PANS and the levels of anti-streptolysin O and anti-DNAse B were higher in PANDAS. Another relevant finding is the efficacy of psychotherapy, especially for obsessive-compulsive disorder, and of antibiotic prophylaxis in managing acute neurological symptoms. Frontiers Media S.A. 2021-09-28 /pmc/articles/PMC8505529/ /pubmed/34650513 http://dx.doi.org/10.3389/fneur.2021.741176 Text en Copyright © 2021 Rea, Guido and Spalice. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Neurology
Rea, Isabella
Guido, Cristiana Alessia
Spalice, Alberto
Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study
title Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study
title_full Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study
title_fullStr Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study
title_full_unstemmed Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study
title_short Clinical Features in Patients With PANDAS/PANS and Therapeutic Approaches: A Retrospective Study
title_sort clinical features in patients with pandas/pans and therapeutic approaches: a retrospective study
topic Neurology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505529/
https://www.ncbi.nlm.nih.gov/pubmed/34650513
http://dx.doi.org/10.3389/fneur.2021.741176
work_keys_str_mv AT reaisabella clinicalfeaturesinpatientswithpandaspansandtherapeuticapproachesaretrospectivestudy
AT guidocristianaalessia clinicalfeaturesinpatientswithpandaspansandtherapeuticapproachesaretrospectivestudy
AT spalicealberto clinicalfeaturesinpatientswithpandaspansandtherapeuticapproachesaretrospectivestudy